Skip to content

Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01518049
Enrollment
50
Registered
2012-01-25
Start date
2012-02-29
Completion date
2014-09-30
Last updated
2015-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Affective Disorders, Psychotic

Keywords

Affective Disorders, Psychotic, Psychometrics, Biological Markers

Brief summary

The aim of this study is to develop a scale to measure the severity of depression with psychotic symptoms (psychotic depression). Furthermore, we hope to detect potential biomarkers (substances in the blood) which can aid in the detection of psychotic depression. Main hypothesis: A clinically valid rating scale measuring the severity of psychotic depression can be developed.

Interventions

None listed

Sponsors

Søren Dinesen Østergaard
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Fulfilling ICD-10 criteria DF32.3 or DF33.3 * At least 18 years old * Legally competent * Informed consent (oral & written)

Exclusion criteria

* Insufficient Danish Language skills * Moderate to severe dementia * Abuse of psychoactive substances

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026